Denosumab 120 mg/ 0.7 ml Injection

About Denosumab 120 mg/ 0.7 ml Injection

Denosurel 120 mg Injection Discription .

Denosurel 120 mg Injection belongs to a group of medicines called RANK ligand inhibitors used to treat osteoporosis in postmenopausal women and men who have an increased risk of fracture. Denosurel 120 mg Injection is also used to treat bone loss due to reduced testosterone level caused by surgery, due to the treatment with medicines such as glucocorticoids and in patients with prostate cancer. Denosurel 120 mg Injection may also be used to reduce the risk of fractures in people with multiple myeloma, giant cell tumour of the bone, and to treat high calcium levels caused by cancer.
 
Denosurel 120 mg Injection contains Denosumab, which works by blocking a receptor in the body that causes bone loss, thereby treating bone loss. Denosurel 120 mg Injection treats giant cell tumour of bone (GCTB) by blocking certain receptors in the tumour cells, thereby slowing the growth of the tumour. Denosurel 120 mg Injection helps treat high calcium levels by decreasing bone breakdown, as a breakdown of the bones releases calcium. Denosurel 120 mg Injection makes the bones stronger and less likely to break.
 
Denosurel 120 mg Injection will be administered by a healthcare professional; do not self-administer. Sometimes, you may experience common side effects such as bone/joint/muscle pain, arm/leg pain, abdominal discomfort, constipation, and painful/frequent urination. You should talk to your doctor if the side effects persist or worsen.
 
Denosurel 120 mg Injection might cause jaw osteonecrosis; therefore, maintain good dental hygiene and receive regular dental check-ups whilst on treatment with Denosurel 120 mg Injection . Avoid taking Denosurel 120 mg Injection if you are pregnant. Consult your doctor before taking Denosurel 120 mg Injection if you are breastfeeding. Denosurel 120 mg Injection is not recommended for children below 18 years as safety and effectiveness have not been established. To rule out any interactions, keep your doctor informed about your health condition and medicines.

Uses of Denosurel 120 mg Injection

Denosurel 120 mg Injection used to treat osteoporosis, bone loss, giant cell tumour of the bone, and high calcium levels. The detailed uses of Denosurel 120 mg Injection are as follows:
Management of Osteoporosis: Denosurel 120 mg Injection treats osteoporosis in postmenopausal women, increasing bone density and reducing fracture risk.
Giant cell tumour of the bone treatment: Denosurel 120 mg Injection is prescribed for the treatment of giant cell tumour of the bone, which helps by reducing tumour size and slowing its growth.
Increases bone mass: Denosurel 120 mg Injection increases bone mass in patients at high risk for fracture, including those undergoing androgen deprivation therapy for prostate cancer or adjuvant aromatase inhibitor therapy for breast cancer.
Hypercalcemia Treatment: Denosurel 120 mg Injection treats hypercalcemia caused by cancer, helping normalise calcium levels in the blood.
Paget's Disease: Denosurel 120 mg Injection treats Paget's disease by alleviating bone pain and complications caused by enlarged and deformed bones.

Directions for Use

Denosurel 120 mg Injection will be administered by a healthcare professional; do not self-administer.

Medicinal Benefits

Denosurel 120 mg Injection belongs to a group of medicines called RANK ligand inhibitors used to treat osteoporosis in postmenopausal women and men who have an increased risk of fracture. Denosurel 120 mg Injection is also used to treat bone loss due to reduced hormone levels caused by surgery or due to treatment with medicines in patients with prostate cancer. It is also used to treat bone loss occurring due to long-term treatment with glucocorticoids in patients who are at an increased risk of fractures. Denosurel 120 mg Injection may also be used to reduce the risk of fractures in people with multiple myeloma, giant cell tumours of the bone and to treat high calcium levels caused by cancer. Denosurel 120 mg Injection binds to a protein on RANK ligand on osteoclast (cells that cause bone breakdown) and inhibits their formation, functioning and survival. It decreases bone breakdown, increases bone density, and strengthens the bone. Denosurel 120 mg Injection treats giant cell tumour of bone (GCTB) by blocking certain receptors in the tumour cells, thereby slowing the growth of the tumour. Denosurel 120 mg Injection helps treat high calcium levels by decreasing bone breakdown, as the breakdown of the bones releases calcium. Denosurel 120 mg Injection makes the bones stronger and less likely to break.

How Denosurel 120 mg Injection Works

Denosurel 120 mg Injection contains Denosumab, which works by blocking a receptor in the body that causes bone loss, thereby treating bone loss. Denosurel 120 mg Injection treats giant cell tumours of bone (GCTB) by blocking specific receptors in the tumour cells, thereby slowing the growth of the tumour. Denosurel 120 mg Injection helps treat high calcium levels by decreasing bone breakdown, as a breakdown of the bones releases calcium. Denosurel 120 mg Injection makes the bones stronger and less likely to break.

Storage

Store in a cool and dry place away from sunlight

Side effects of Denosurel 120 mg Injection 1.7 ml

Weakness

Back Pain

Joint Pain

Pain In Arm Or Leg

Headache

Cough